MTHFR A1298C polymorphisms reduce the risk of congenital heart defects: a meta-analysis from 16 case-control studies

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) plays a crucial role in the hyperhomocysteinemia, which is a risk factor related to the occurrence of congenital heart defect (CHD). However, the association between MTHFR polymorphism and CHD has been inconclusive. METHODS: We conducted an upd...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Di, Zhuang, Zhulun, Wen, Zhongyuan, Zang, Xiaodong, Mo, Xuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715640/
https://www.ncbi.nlm.nih.gov/pubmed/29202788
http://dx.doi.org/10.1186/s13052-017-0425-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715640/
https://www.ncbi.nlm.nih.gov/pubmed/29202788
http://dx.doi.org/10.1186/s13052-017-0425-1

Ejemplares similares